Higher Infection of Dengue Virus Serotype 2 in Human Monocytes of Patients with G6PD Deficiency

The prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency is high in Asia. An ex vivo study was conducted to elucidate the association of G6PD deficiency and dengue virus (DENV) infection when many Asian countries are hyper-endemic. Human monocytes from peripheral mononuclear cells collected from 12 G6PD-deficient patients and 24 age-matched controls were infected with one of two DENV serotype 2 (DENV-2) strains–the New Guinea C strain (from a case of dengue fever) or the 16681 strain (from a case of dengue hemorrhagic fever) with a multiplicity of infection of 0.1. The infectivity of DENV-2 in human monocytes was analyzed by flow cytometry. Experimental results indicated that the monocytes of G6PD-deficient patients exhibited a greater levels of infection with DENV-2 New Guinea C strain than did those in healthy controls [mean±SD:33.6%±3.5 (27.2%∼39.2%) vs 20.3%±6.2 (8.0%∼30.4%), P<0.01]. Similar observations were made of infection with the DENV-2 16681 strain [40.9%±3.9 (35.1%∼48.9%) vs 27.4%±7.1 (12.3%∼37.1%), P<0.01]. To our knowledge, this study demonstrates for the first time higher infection of human monocytes in G6PD patients with the dengue virus, which may be important in increasing epidemiological transmission and perhaps with the potential to develop more severe cases pathogenically.

[1]  Chun-Nan Lee,et al.  Differences in replication capacity between enterovirus 71 isolates obtained from patients with encephalitis and those obtained from patients with herpangina in Taiwan , 2007, Journal of medical virology.

[2]  D. Gubler,et al.  Risk factors for infection during a dengue-1 outbreak in Maui, Hawaii, 2001. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[3]  E. Harris,et al.  Dendritic Cell Precursors Are Permissive to Dengue Virus and Human Immunodeficiency Virus Infection , 2005, Journal of Virology.

[4]  A. Tärnvik,et al.  Distinct Roles of Reactive Nitrogen and Oxygen Species To Control Infection with the Facultative Intracellular Bacterium Francisella tularensis , 2004, Infection and Immunity.

[5]  D. Gubler,et al.  The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle? , 2004, Comparative immunology, microbiology and infectious diseases.

[6]  M. Lai,et al.  Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells , 2004, Hepatology.

[7]  C. King,et al.  High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. , 2003, Virology.

[8]  C. Villarreal-Garza,et al.  HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever. , 2002, Human immunology.

[9]  M. de Boer,et al.  Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. , 2002, Blood.

[10]  May-Jen Huang,et al.  Glucose-6-phosphate dehydrogenase deficiency, the UDP-glucuronosyl transferase 1A1 gene, and neonatal hyperbilirubinemia. , 2002, Gastroenterology.

[11]  Giorgio Gabella,et al.  Killing activity of neutrophils is mediated through activation of proteases by K+ flux , 2002, Nature.

[12]  D. Gubler Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. , 2002, Trends in microbiology.

[13]  V. Viprakasit,et al.  Effect of red blood cell glucose-6-phosphate dehydrogenase deficiency on patients with dengue hemorrhagic fever. , 2002, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[14]  J. Vasconcelos,et al.  Neutrophil dysfunction in a case of glucose-6-phosphate dehydrogenase deficiency. , 2002, Journal of pediatric hematology/oncology.

[15]  I. Gotsman,et al.  Glucose‐6‐phosphate dehydrogenase deficiency is associated with increased initial clinical severity of acute viral hepatitis A , 2001, Journal of gastroenterology and hepatology.

[16]  C. King,et al.  Flow Cytometry Compared with Indirect Immunofluorescence for Rapid Detection of Dengue Virus Type 1 after Amplification in Tissue Culture , 2001, Journal of Clinical Microbiology.

[17]  H. Fujii,et al.  Distribution of glucose-6-phosphate dehydrogenase mutations in Southeast Asia , 2001, Human Genetics.

[18]  D. Chang,et al.  Infection of Human Dendritic Cells by Dengue Virus Causes Cell Maturation and Cytokine Production1 , 2001, The Journal of Immunology.

[19]  C. King,et al.  Bacterial Lipopolysaccharide Inhibits Dengue Virus Infection of Primary Human Monocytes/Macrophages by Blockade of Virus Entry via a CD14-Dependent Mechanism , 1999, Journal of Virology.

[20]  E. R. Stiehm,et al.  Decreased Superoxide Anion and Hydrogen Peroxide Production by Neutrophils and Monocytes in Human Immunodeficiency Virus-Infected Children and Adults , 1993, Pediatric Research.

[21]  D. Gubler,et al.  Dengue and dengue hemorrhagic fever. , 2014 .

[22]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.

[23]  R. Hann,et al.  Incidence and causes of sepsis in glucose-6-phosphate dehydrogenase-deficient newborn infants. , 1989, The Journal of pediatrics.

[24]  S. Halstead,et al.  Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. , 1989, Reviews of infectious diseases.

[25]  G. C. Mills,et al.  Glucose-6-phosphate dehydrogenase deficiency, neutrophil dysfunction and Chromobacterium violaceum sepsis. , 1987 .

[26]  J. Vives Corrons,et al.  Severe-glucose-6-phosphate dehydrogenase (G6PD) deficiency associated with chronic hemolytic anemia, granulocyte dysfunction, and increased susceptibility to infections: description of a new molecular variant (G6PD Barcelona). , 1982, Blood.

[27]  G. Stamatoyannopoulos,et al.  Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase. , 1973, Lancet.

[28]  H. Notopuro,et al.  Glucose-6-phosphate dehydrogenase deficiency. , 1972, Paediatrica Indonesiana.

[29]  D. Gubler,et al.  Major epidemics of dengue in Taiwan in 1981-2000: related to intensive virus activities in Asia. , 2000 .

[30]  S. Chiang,et al.  Neonatal screening for glucose-6-phosphate dehydrogenase deficiency in Taiwan. , 1999, The Southeast Asian journal of tropical medicine and public health.

[31]  A. Nisalak,et al.  Isolation of dengue viruses from peripheral blood leukocytes of patients with hemorrhagic fever. , 1980, The Journal of infectious diseases.

[32]  A. Gehani,et al.  [G6PD deficiency]. , 1974, Xianggang hu li za zhi. The Hong Kong nursing journal.

[33]  S. Newsom,et al.  Letter: Local chemotherapy for pseudomonas lung abscess. , 1974, Lancet.